The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists
- PMID: 15147282
- DOI: 10.1111/j.1472-8206.2004.00236.x
The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists
Abstract
Sympathetic neurotransmission in tissues with intact sympathetic nerve arborization is extensively dependent on calcium influx via N-type calcium-channels. It was the objective of the present study to assess and compare the claimed sympatholytic effect of the 1,4-dihydropyridine compound cilnidipine with other voltage-dependent calcium-channel (VDCC) antagonists. We studied these compounds by means of three different models. In the rabbit isolated thoracic aorta, the alleged sympatholytic properties displayed by these compounds were evaluated in the noradrenaline spillover model. Additionally, the influence of cilnidipine on stimulation-induced constrictor responses was studied in the rat isolated tail artery (male Wistar rats, 250-300 g) in addition to its effect on noradrenaline-induced contractions. Finally, we studied the influence of cilnidipine and other calcium-channel blockers on stimulation-induced chronotropic responses, in order to address N- or L-type selectivity, in the pithed rat model (male Wistar rats, 260-320 g). Furthermore, we evaluated their effect on noradrenaline-induced tachycardia. In the isolated rabbit thoracic aorta preparation omega-conotoxin GVIA (0.1 microM) nearly abolished the sympathetic outflow caused by stimulation, whereas nifedipine (0.1 microM) and amlodipine (1 microM) did not influence the evoked noradrenaline release. Cilnidipine (1 microM) significantly attenuated the response by nearly 18% and mibefradil (1 microM) by c. 42%. The stimulation-induced constrictor response (prejunctional effect) in the rat isolated tail artery could be blocked by omega-conotoxin GVIA (0.5 and 1 microM). Cilnidipine (10 nm and 0.1 microM) significantly attenuated responses to stimulation by maximally 20%, whereas it did not influence the constrictor response to noradrenaline (postjunctional effect). The mean heart rate in the pithed rat model amounted to 309.3 +/- 3.6 beats/min (bpm). Electrical stimulation of the cardio-accelerator nerves (C7-Th1) resulted in an increase by 106.7 +/- 2.2 bpm. All antagonists studied, except for nifedipine, attenuated the chronotropic response to stimulation (P < 0.05). The rank order of sympatholytic efficacy was: omega-conotoxin GVIA (84.8%), mibefradil (75.1%), cilnidipine (43.0%) and amlodipine (34.8%). Noradrenaline (10 nmol/kg) increased the heart rate by 117.8 +/- 2.7 bpm. This chronotropic response was influenced equally well by the calcium-channels blockers as observed in the stimulation (prejunctional) experiment. In conclusion, the N-type channel blocking properties and thus sympatholytic effect of cilnidipine could be demonstrated in some (vascular) but not all (cardiac) models studied. At the level of the vasculature cilnidipine reduced the neurotransmitter release to electrical stimulation in both the noradrenaline spillover model and in the model of the rat isolated tail artery, respectively. For amlodipine and nifedipine no sympatholytic activity could be demonstrated. In the pithed rat model, we were unable to demonstrate a selective N-type blocking effect for the VDCC-antagonists.
Similar articles
-
Effect of omega-conotoxin GVIA on noradrenaline release from postganglionic sympathetic neurones in rabbit aorta.Pharmacol Toxicol. 2000 Jan;86(1):30-5. Pharmacol Toxicol. 2000. PMID: 10720104
-
Effects of N- and L-type calcium channel antagonists and (+/-)-Bay K8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands.Br J Pharmacol. 1997 Jun;121(3):381-8. doi: 10.1038/sj.bjp.0701131. Br J Pharmacol. 1997. PMID: 9179377 Free PMC article.
-
Characterization of Ca(2+)-channels responsible for K(+)-evoked [(3)H]noradrenaline release from rat brain cortex synaptosomes and their response to amyotrophic lateral sclerosis IgGs.Exp Neurol. 1999 Oct;159(2):520-7. doi: 10.1006/exnr.1999.7164. Exp Neurol. 1999. PMID: 10506523
-
[Calcium antagonists: current and future applications based on new evidence. Neuroprotective effect of calcium antagonists].Clin Calcium. 2010 Jan;20(1):83-8. Clin Calcium. 2010. PMID: 20048438 Review. Japanese.
-
Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release.Cardiovasc Ther. 2009 Summer;27(2):124-39. doi: 10.1111/j.1755-5922.2009.00079.x. Cardiovasc Ther. 2009. PMID: 19426250 Review.
Cited by
-
The fourth-generation Calcium channel blocker: cilnidipine.Indian Heart J. 2013 Dec;65(6):691-5. doi: 10.1016/j.ihj.2013.11.001. Indian Heart J. 2013. PMID: 24407539 Free PMC article. Review.
-
New Insights into the Nephroprotective Potential of Lercanidipine.Int J Mol Sci. 2023 Sep 13;24(18):14048. doi: 10.3390/ijms241814048. Int J Mol Sci. 2023. PMID: 37762350 Free PMC article. Review.
-
Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects.Heart Vessels. 2007 Nov;22(6):404-9. doi: 10.1007/s00380-007-0984-y. Epub 2007 Nov 26. Heart Vessels. 2007. PMID: 18043999
-
Oral administration of cilnidipine to patients with hypertensive intracerebral hemorrhage in the acute stage: significance and role of an N-type calcium channel blocker.Ir J Med Sci. 2009 Dec;178(4):419-22. doi: 10.1007/s11845-008-0224-1. Ir J Med Sci. 2009. PMID: 18841437
-
Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers.Curr Ther Res Clin Exp. 2023 Sep 30;99:100717. doi: 10.1016/j.curtheres.2023.100717. eCollection 2023. Curr Ther Res Clin Exp. 2023. PMID: 37869401 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous